期刊文献+

胍丁胺对神经退行性病变保护作用的研究现状 被引量:1

在线阅读 下载PDF
导出
摘要 胍丁胺(AGM)是精氨酸脱羧酶催化精氨酸脱羧基的产物,能被胍丁胺酶水解成腐胺。AGM作为一种神经递质,分布于大脑皮质、低位脑干、中脑及下丘脑等部位,以下丘脑含量最高[1]。在亚细胞水平AGM主要存在于细胞质、内质网和线粒体中[1]。AGM在脑和脊髓中合成,储存于突触小泡内,通过突触前膜的去极化而释放,参与内分泌、内脏活动、情感、认知和疼痛的中枢调节作用。
出处 《成都医学院学报》 CAS 2016年第2期267-269,272,共4页 Journal of Chengdu Medical College
基金 四川省教育厅科研基金资助项目(No:12ZB204 15ZA0251) 成都医学院自然科学基金(No:CYZ14-010)
作者简介 通信作者:杨永录,E-mail:ylyang9@sohu.com
  • 相关文献

参考文献21

  • 1Uzbay TI.The pharmacological importance of agmatine in the brain[J].Neurosci Biobehav Rev,2012,36(1):502-519.
  • 2Whittington RA,Papon MA,Chouinard F,et al.Hypothermia and Alzheimer′s disease neuropathogenic pathways[J].Curr Alzheimer Res,2010,7(8):717-725.
  • 3杨永录,卜舒.低温在阿尔茨海默病发病中作用的研究现状[J].实用老年医学,2014,28(8):681-684. 被引量:2
  • 4Arndt MA,Battaglia V,Parisi E,et al.The arginine metabolite agmatine protects mitochondrial function and confers resistance to cellular apoptosis[J].Am J Physiol,Cell Physiol,2009,296(6):1411-1419.
  • 5Su B,Wang X,Nunomura A,et al.Oxidative stress signaling in Alzheimer′s disease[J].Curr Alzheimer Res,2008,5(6):525-532.
  • 6Iizuka Y,Hong S,Kim CY,et al.Agmatine pretreatment protects retinal ganglion cells(RGC-5 cell line)from oxidative stress in vitro[J].Biocell,2008,32(3):245-250.
  • 7Querfurth HW,LaFerla FM.Alzheimer′s disease[J].N Engl J Med,2010,362(4):329-344.
  • 8Sultana R,Butterfield DA.Role of oxidative stress in the progression of Alzheimer′s disease[J].J Alzheimers Dis,2010,19(1):341-353.
  • 9Zhao WQ,Alkon DL.Role of insulin and insulin receptor in learning and memory[J].Mol Cell Endocrinol,2001,177(1-2):125-134.
  • 10Erickson MA,Dohi K,Banks WA.Neuroinflammation:a common pathway in CNS diseases as mediated at the bloodbrain barrier[J].Neuroimmunomodulation,2012,19(2):121-130.

二级参考文献112

  • 1武凤英,冯琼,程敏,闫洁,许玉霞,朱粹青.兴奋性氨基酸受体的激活介导冷水应激诱导的tau蛋白磷酸化(英文)[J].生物化学与生物物理进展,2010,37(5):510-516. 被引量:13
  • 2Traynelis S F, Wollmuth L P, McBain C J, et al. Glutamate receptor ion channels: structure, regulation and function. Pharmacol Rev, 2010,62(3): 405-496.
  • 3Henneberger C, Bard L, King C, et al. NMDA receptor activation: two targets for two Co-agonists. Neurochem Res, 2013, 38 (6): 1156-1162.
  • 4Li Y, Sacchi S, Pollegioni L, et al. Identity of endogenous NMDAR glycine site agonist in amygdala is determined by synaptic activity level. Nat Commun, 2013, 4: 1760.
  • 5Henneberger C, Papouin T, Oliet S H R, et al. Long-term potentiation depends on release ofD-serine from astrocytes. Nature, 2010,463(7278):232-236.
  • 6Fossat P, Turpin F R, Sacchi S, et al. Glial D-serine gates NMDA receptors at excitatory synapses in prefrontal cortex. Cereb Cortex, 2012, 22(3): 595-606.
  • 7Pina-Crespo J C, Talantova M, Micu I, et al. Excitatory glycine responses ofCNS myelin mediated by NRIINR3 "NMDA" receptor subunits. J Neurosci, 2010, 30(34): 11501-11505.
  • 8Matsuda K, Kamiya Y, Matsuda S, et al. Cloning and characterization of a novel NMDA receptor subunit NR3B: a dominant subunit that reduces calcium permeability. Molecular Brain Research, 2002, 100(1-2): 43-52.
  • 9Pachernegg S, Strutz-Seebohm N, Hollmann M. GluN3 subunitcontaining NMDA receptors: not just one-trick ponies. Trends in Neurosciences, 2012, 35(4): 240-249.
  • 10Siegler Retchless B, Gao W, Johnson J W. A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction. Nature Neuroscience, 2012, 15 (3): 406-413, SI-2.

共引文献20

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部